- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05611996
PEERS Plus mHealth Enhanced Peer Support (Peers plus)
September 22, 2025 updated by: Jin hui Joo, MD, MA, Massachusetts General Hospital
PEERS Plus - mHealth Enhanced Peer Support to Reduce Depression Among Low-income and Ethnic Minority Older Adults
The goal of this intervention study is to design and learn whether peer support that is delivered through video chats and texts can decrease depression among older adults.
Participants will be assigned to a peer support program where they will receive 8 video chats with a peer mentor who provide social support and supportive texts over 8 weeks.
Study Overview
Detailed Description
PEERS plus is a psychosocial intervention being developed to reduce depression among older adults.
In this intervention peer mentors who are also 50 years of age and older and who have experiential knowledge of depression provide depression care.
Older adults with depression will be recruited and assigned to the peer support program.
This will consist of 8 weekly peer mentor - older adult video chats that provide emotional support and sharing of self-care skills for depression.
Supportive texts will be sent on a weekly basis to older adults by peer mentors.
These texts will provide encouragement, affirmations and information about mental health resources.
Peer mentors are trained and supervised by a mental health professional during the 8 week period.
We will assess at baseline, post study and 3 months after the intervention.
Study Type
Interventional
Enrollment (Actual)
34
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
46 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 50 years and older
- PHQ-9 score > 5,
- on the same antidepressant dose for at least 3 months
- if receiving psychotherapy, frequency is at most once a month
- able to communicate in English
- able to give informed consent.
Exclusion Criteria:
- meet diagnostic criteria for mania or hypomania
- active suicidal ideation
- meet diagnostic criteria for psychotic syndrome
- meet diagnostic criteria for substance abuse or dependence
- cognitive impairment, with a score on the Short Blessed Test > 9.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Peer support
Peer mentors who have experienced depression provide social support through video chats and texts for 8 weeks.
|
Peer support intervention in which peer mentors who have experiential knowledge of depression deliver social support through video chats and texts to older adults with depression.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intervention Feasibility
Time Frame: 18 months
|
Proportion of the participants who complete 80% of their weekly meetings with the peer coach.
|
18 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Health Questionnaire-9
Time Frame: We assessed PHQ-9 scores as changes across three timepoints: baseline, post study and 3 month follow up. We ran a mixed-effects longitudinal model to examine how PHQ-9 scores changed over 5 months (8 week intervention and 3 month follow up).
|
Depression will be assessed with the Patient Health Questionnaire (PHQ-9).
The PHQ-9 score is summed from 9 items in the questionnaire, and scores range from 0 to 27.
A higher score indicates a worse outcome in depression.
A score of 5 indicates mild depressive symptoms, 10 - 14 indicates moderate depression, 15-19 indicates moderately severe depression, and 20-27 indicates severe depression.
|
We assessed PHQ-9 scores as changes across three timepoints: baseline, post study and 3 month follow up. We ran a mixed-effects longitudinal model to examine how PHQ-9 scores changed over 5 months (8 week intervention and 3 month follow up).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 15, 2022
Primary Completion (Actual)
January 17, 2025
Study Completion (Actual)
January 17, 2025
Study Registration Dates
First Submitted
November 3, 2022
First Submitted That Met QC Criteria
November 3, 2022
First Posted (Actual)
November 10, 2022
Study Record Updates
Last Update Posted (Estimated)
October 8, 2025
Last Update Submitted That Met QC Criteria
September 22, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022P001984
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression in Old Age
-
The University of Texas Health Science Center,...Department of Health and Human ServicesRecruitingDepression in Old AgeUnited States
-
University Hospital, Strasbourg, FranceRecruitingDepression in Old AgeFrance
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH)Completed
-
Yale UniversityCompletedCognitive Function | Depression in Old AgeUnited States
-
The University of Hong KongTung Wah Group of HospitalsCompleted
-
Kahramanmaras Sutcu Imam UniversityCompletedFalls (Accidents) in Old Age | Malnutrition Elderly | Depression in Adults | Post-Traumatic Stress Disorder in Old Age | Frailty at Older AdultsTurkey (Türkiye)
-
University of IbadanNot yet recruiting
-
The University of Hong KongRecruitingDepression in Old AgeHong Kong
-
Hospital Center Guillaume RégnierCompleted
-
Queens College, The City University of New YorkNational Institute of Mental Health (NIMH); New York State Psychiatric InstituteWithdrawnDepression | Depression in Old AgeUnited States
Clinical Trials on Peers plus
-
University of Wisconsin, MadisonCompleted
-
University of Kansas Medical CenterNational Institute of Nursing Research (NINR)CompletedMalnutrition | Malabsorption | Short Bowel SyndromeUnited States
-
University of Wisconsin, MilwaukeeNF MidwestActive, not recruitingSocial Skills | Neurofibromatosis 1United States
-
National Taiwan University HospitalRecruitingAutism Spectrum DisorderTaiwan
-
Bar-Ilan University, IsraelUnknownSocial Skills | Parent-Child Relational ProblemIsrael
-
University of Wisconsin, MadisonCompletedMedication Adherence | Type2 Diabetes | Medication Nonadherence | Peer SupportUnited States
-
University College, LondonLiverpool School of Tropical Medicine; Ministry of Health and Child Welfare... and other collaboratorsNot yet recruitingHIV Prevention | Adherence, Medication | Contraceptive UsageZimbabwe
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)Completed
-
Bar-Ilan University, IsraelIsrael Science FoundationRecruitingAutism Spectrum DisorderIsrael
-
Children's Hospital Medical Center, CincinnatiEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingAutism Spectrum DisorderUnited States